NVP-TAE684 Reverses Multidrug Resistance (MDR) in Human Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function

British Journal of Pharmacology- United States

doi 10.1111/bph.13395

Full Text

Abstract

Available in

Categories

Date

January 15, 2016

Authors

Nathanael S Gray

Francis J Hornicek

Publisher

Wiley

Related search

Bafetinib (INNO-406) Reverses Multidrug Resistance by Inhibiting the Efflux Function of ABCB1 and ABCG2 Transporters

Scientific Reports

Multidisciplinary

English

P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma

Anticancer Research

Cancer Research

English

HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein

Multidisciplinary

English

Location of the Rhodamine-Binding Site in the Human Multidrug Resistance P-Glycoprotein

Journal of Biological Chemistry

Molecular Biology

English

P‐Glycoprotein, Multidrug Resistance and Protein Kinase C

Cancer Research

English

MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters

Cancer Research

English

Membrane Transport of Camptothecin: Facilitation by Human P-Glycoprotein (ABCB1) and Multidrug Resistance Protein 2 (ABCC2)

English

Multidrug-Resistance P-Glycoprotein (MDR1) Secretes Platelet-Activating Factor

Biochemical Journal

Molecular Biology

English

Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells

Scientific Reports

Multidisciplinary

English